Roll out of intraveneous artesunate under named patient programmes in the Netherlands, Belgium and France

BACKGROUND: Intravenous (IV) artesunate is the treatment of choice for severe malaria. In Europe, this treatment is only available in a few countries via named patient programmes (NPPs). As a case study, the legal and organisational aspects and pharmacovigilance of these NPPs and possibilities for h...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Kreeftmeijer-Vegter, Annemarie Rosan, van Veldhuizen, Cornelis KW, de Vries, Peter J
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2013
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3848968/
https://ncbi.nlm.nih.gov/pubmed/24063858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1750-1172-8-150
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki